This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Chengxi Li: Innovator in Pharmaceutical Chemistry
Introduction
Chengxi Li is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on urea derivatives. His research focuses on developing compounds that can be utilized in medical applications.
Latest Patents
Chengxi Li holds a patent for a "Salt of substituted urea derivative and use thereof in medicine." This patent describes a salt of a substituted urea derivative of formula (I) and its applications in the pharmaceutical field. The invention includes a pharmaceutical composition containing the salt and outlines its use in the manufacture of a medicament for treating, remitting, or preventing disorders related to tyrosine kinase activity. This work highlights the potential of his invention in addressing critical medical issues.
Career Highlights
Chengxi Li is currently employed at Sunshine Lake Pharma Co., Ltd. His role at the company allows him to apply his expertise in pharmaceutical chemistry to develop innovative solutions for healthcare. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Chengxi Li collaborates with talented professionals in his field, including Liang Chen and Bing Liu. These partnerships enhance the research and development efforts at Sunshine Lake Pharma Co., Ltd., fostering an environment of innovation and creativity.
Conclusion
Chengxi Li's contributions to pharmaceutical chemistry through his patented inventions demonstrate his commitment to advancing medical science. His work not only showcases his innovative spirit but also has the potential to impact the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile